The following articles (labelled with PubMed ID or TBD) are for your review
| PMID | Data | Article Title | Organization |
|---|
| 26752095 |
12 |
Design and synthesis of calindol derivatives as potent and selective calcium sensing receptor agonists. |
Cnrs |
| 26516782 |
59 |
Selective Allosteric Antagonists for the G Protein-Coupled Receptor GPRC6A Based on the 2-Phenylindole Privileged Structure Scaffold. |
University of Copenhagen |
| 16913701 |
8 |
N1-Benzoyl-N2-[1-(1-naphthyl)ethyl]-trans-1,2-diaminocyclohexanes: Development of 4-chlorophenylcarboxamide (calhex 231) as a new calcium sensing receptor ligand demonstrating potent calcilytic activity. |
Cnrs |
| 15149704 |
3 |
N2-benzyl-N1-(1-(1-naphthyl)ethyl)-3-phenylpropane-1,2-diamines and conformationally restrained indole analogues: development of calindol as a new calcimimetic acting at the calcium sensing receptor. |
Upr 2301 Centre National De La Recherche Scientifique |
| 19442519 |
14 |
The discovery of novel calcium sensing receptor negative allosteric modulators. |
Pfizer |
| 16216508 |
44 |
Discovery of novel 1-arylmethyl pyrrolidin-2-yl ethanol amines as calcium-sensing receptor antagonists. |
Bristol-Myers Squibb Pharmaceutical Research Institute |
| 29724589 |
40 |
Discovery of evocalcet, a next-generation calcium-sensing receptor agonist for the treatment of hyperparathyroidism. |
Mitsubishi Tanabe Pharma |
| 28916340 |
23 |
Identification of potent, nonabsorbable agonists of the calcium-sensing receptor for GI-specific administration. |
Glaxosmithkline |
Search and Browse
